- Global Pharma News & Resources

Plasma Protein Therapeutics Market surpassed US$ 24 Bn in 2021, owing to increasing prevalence of cancer | insightSLICE

The global Plasma Protein Therapeutics market size was estimated to be US$ 24 billion in 2021 and is expected grow at a CAGR of 4.5% between 2023 to 2032.

The plasma Protein Therapeutics Market Report will provide insights into Global Share, Developments, Statistics, and Forecasts, for the year 2022-2032.

This study also takes into account the competitive environment and will give an outline of the top market participants in the Plasma Protein Therapeutics Market as well as their plans for the market.

Access the sample report:

Additionally, the report will also include statistics regarding important advancements, global and regional sales networks, business strategies, research and development initiatives, staff strength, and key executives for all significant market participants.

The key players of the Global Plasma Protein Therapeutics Market are:

Biotest Pharmaceuticals Corporation, Baxter International Inc., CSL Behring, China Biologic Products, Inc., GRIFOLS, S.A, Octapharma USA, Inc., Kedrion S.p.A., and Shire Plc.

Reasons for the growth of plasma protein therapeutics:

The global market for plasma protein therapies is very intense and subject to strict restrictions. In advanced economies, plasma collection requirements are rigorous and there is a tight regulatory structure in place to preserve operational quality.

Health officials keep an eye on the fractionation process to prevent poor plasma purity and guarantee that the originating plasma is free of infectious agents like Parvovirus B, hepatitis A, B, and C, and HIV.

To ensure safe operation & effectiveness, donor safety, biological licensing, conformity, and pharmacovigilance, the plasma protein treatment cycle is intricate and closely regulated. Because of the rise in primary immunodeficiencies, there is a large global increase in the requirement for immunoglobulin (PID).

As a consequence, there are now more clinical uses, including those for autoimmune and acute inflammatory illnesses.

The primary driver of the expansion of the market plasma protein therapeutics market is the rising demand for plasma therapeutic proteins for the intervention of autoimmune neurologic diseases, hemolytic disease of the newborn, autoimmune mucocutaneous blistering diseases, acute cardiomyopathy, multifocal motor neuropathy (MMN), and acute panautonomic polyneuropathy.

Read more about the report inclusions:

Major players and their strategies are covered in our report:

The players involved in the plasma ecosystem and their contributions will be taken into account in the global plasma protein therapies market study. All of the products in the company’s plasma protein therapies business sector would be the main focus of the product portfolio segment of this report.

Similar to this, the recent developments section will concentrate on the most recent corporate developments, including global expansion, mergers and acquisitions, the introduction of new products, and strategic partnerships and alliances in the worldwide plasma protein therapeutics market.

Every one of the Plasma Protein Therapeutics Products along with their business strategies, product portfolios, important developments, SWOT analyses, and research and development priorities are taken into account in the study.

The companies involved in the Plasma Protein Therapeutics market ecosystem and their contributions will be taken into account in this report. All of the products delivered by the company’s Plasma Protein Therapeutics division would be the main emphasis of the product portfolio section of our report.

Similarly, the recent developments section from this report will concentrate on the latest developments, such as regional expansion, mergers, and acquisitions, and also track the launch of new products, and strategic alliances in the global Plasma Protein Therapeutics market.

Related reports:

Global Smart Healthcare Market:

Global Resuscitation Devices Market:

Global Plasma Protein Therapeutics Market Key Segments:

By Product

  • Albumin
  • Immunoglobulin
  • Factor VIII

By Application

  • Hemophilia
  • Primary Immunodeficiency Disorder (PID)
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Others

By Geography:

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

Regional performance of Plasma Protein Therapeutics Market

Due to the increased demand, growing elderly population, and accessibility of a reliable plasma donation network, North America accounted for the highest share of the global market for plasma protein therapies in 2019. To increase their existing network, the top players in North America are likely to buy minor plasma donation facilities.

They may also heavily invest in the construction of new plasma donation facilities across the region. Market competitiveness has increased as a result of such practices, which are expected to help patients with plasma insufficiency.

During the projected period, plasma protein therapeutics are expected to see the fastest growth in the Asia Pacific region.

The market for plasma protein therapeutics in the Asia Pacific is anticipated to be supported by an increase in the number of patients with primary immunodeficiencies (PID) and hemophilia across the major nations in this region.

This growth will also be facilitated by the rising awareness of the benefits of plasma transplantation and a growing healthcare infrastructure. Additionally, various governments are aggressively promoting plasma donation and providing incentives to donors, which is expected to boost the expansion of Asia Pacific plasma protein treatments.

Proceed to purchase:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 29-Nov-2022